[Lobular carcinoma in situ as a component of breast cancer points to no contraindication for breast-conserving therapy].
Sautter-Bihl
M L
ML
D001943:Breast Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D002278:Carcinoma in Situ / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery*; D018275:Carcinoma, Lobular / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery*; D005260:Female; D006801:Humans; D015412:Mastectomy, Segmental; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies
Das Carcinoma lobulare in situ als Zusatzbefund bei invasivem Mammakarzinom stellt keine Kontraindikation für eine brusterhaltende Therapie dar.